“…The substrate and inhibitor properties of these compounds toward the mammalian ADA have already been described in literature [10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] (Table 2). This group of compounds includes analogues prone to deamination with this enzyme [10, 12, 14, 16-18, 25, 26], the competitive enzyme inhibitors [11,13,[18][19][20][21]26], the nucleosides with no effect on the kinetics of adenosine deamination [13, 15, 19, 20, and 22-25], and the nucleosides whose substrate properties have not been studied [27][28][29][30][31][32][33][34][35][36][37][38].…”